clinical trial · NCT07493057
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy
Obstructive Sleep Apnea (OSA)PlaceboGZR18 injection
brief summary
This study is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical trial evaluating the efficacy and safety of GZR18 injection in obese subjects with moderate to severe obstructive sleep apnea who are unable or unwilling to undergo positive airway pressure (PAP) therapy.
started
Apr 27, 2026
primary completion
Nov 14, 2027
completion
Nov 14, 2027
last updated
Mar 27, 2026
official title
A Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Moderate to Severe Obstructive Sleep Apnea（OSA） Not Treated With Positive Airway Pressure（PAP）
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol